© 2025 Der Aktionär TV
Aktien»Nachrichten»AMAZON AKTIE»Opening Bell: Amazon, KB Home, Nvidia, Marvell Technology, United Health, Moderna
Tradegate
11.02.25
21:58 Uhr
224,50 Euro
-1,70
-0,75 %
-0,75 %
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 224,50 | 224,75 | 11.02. | |
| 0,000 | 0,000 | 11.02. |
Opening Bell: Amazon, KB Home, Nvidia, Marvell Technology, United Health, Moderna
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 01:06 | Amazon And Google-Backed AI Firm Anthropic Urges Job Seekers: Please Don't Use AI To Apply Here | ||
| 00:38 | Amazon reduziert Preise für Google Pixel 9 um bis zu 300 US-Dollar | ||
| 00:26 | Amazon Kindle Paperwhite 2024: Ein attraktives Angebot für Leseratten | ||
| 00:26 | Here are Three Reasons to Like Amazon.com (AMZN) | ||
| Di | Amazon opens beauty and personal care store in Italy as part of brick-and-mortar expansion |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Do | Dividendenbekanntmachungen (06.02.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ALLIANCEBERNSTEIN GLOBAL HIGH INCOME FUN ... US01879R1068 0,0655 USD 0,0629 EUR ALLIANCEBERNSTEIN NATIONAL MUNICIPAL INC ... US01864U1060 0... ► Artikel lesen | |
| 28.01. | KB Home (NYSE:KBH) Given New $65.00 Price Target at Wells Fargo & Company | ||
| 27.01. | KB HOME - 8-K, Current Report | ||
| 27.01. | KB Home (NYSE:KBH) Stock Price Up 5.4% - What's Next? | ||
| 24.01. | KB HOME - 10-K, Annual Report |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 00:26 | Here's Why Marvell Technology (MRVL) Stock Gets A Bad Rep | ||
| Di | A Closer Look at Marvell Tech's Options Market Dynamics | ||
| Di | Cambiar Investors LLC Has $2.50 Million Stock Holdings in Marvell Technology, Inc. (NASDAQ:MRVL) | ||
| Di | Behind Marvell Tech's Multi-Fold Growth: R&D, Acquisitions And AI Infrastructure | ||
| Sa | Here's Why Marvell Technology Inc. (MRVL) Crashed on Friday |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Di | What the Options Market Tells Us About Moderna | ||
| Di | Moderna stock target cut at BofA as key challenges persist | ||
| Di | Moderna Stock: A Deep Dive Into Analyst Perspectives (11 Ratings) | ||
| Mo | Why Moderna Inc. (MRNA) Crashed Last Week | ||
| So | Estee Lauder, Moderna And PayPal Are Among Top 10 Large Cap Losers Last Week (Feb 3-Feb 7): Are The Others In Your Portfolio? |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 00:42 | $100 Invested In NVIDIA 20 Years Ago Would Be Worth This Much Today | ||
| 00:35 | Should you buy Nvidia stock before February 26? History has a clear answer | ||
| 00:26 | Analyst Sees 'Massive Tailwinds' For Nvidia (NVDA) Despite Valuation Concerns | ||
| Di | Nvidia Partner Supermicro Cuts Fiscal 2025 Estimates, But Sees Big Growth Next Year | ||
| Di | Nvidia CDR (CAD Hedged): Nvidia CDR to be delisted from Cboe Canada |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mo | UnitedHealth Group (UNH): The Best Health Insurance Stock to Buy in 2025 | ||
| Sa | UnitedHealth Group Incorporated (NYSE:UNH) Position Lowered by Appleton Partners Inc. MA | ||
| Fr | How Is The Market Feeling About UnitedHealth Group? | ||
| Do | Meritage Portfolio Management Sells 7,977 Shares of UnitedHealth Group Incorporated (NYSE:UNH) | ||
| 05.02. | UnitedHealth raises concerns over Bill Ackman's post on X with SEC |
5-Tage-Chart
AMAZON
AMAZON
| Unternehmen / Aktien | Kurs | % |
|---|---|---|
| AMAZON.COM INC | 224,50 | -0,75 % |
| KB HOME | 62,00 | -0,80 % |
| MARVELL TECHNOLOGY INC | 105,28 | -3,78 % |
| MODERNA INC | 30,375 | -3,49 % |
| NVIDIA CORPORATION | 128,16 | -1,07 % |
| UNITEDHEALTH GROUP INC | 515,00 | -0,48 % |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen.
Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen,
bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen
Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu
verstehen sein kann.
